NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.980
-0.020 (-1.00%)
At close: Jul 15, 2025, 4:00 PM
2.010
+0.030 (1.52%)
After-hours: Jul 15, 2025, 4:31 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $47.50 million as of July 15, 2025. Its market cap has increased by 209.22% in one year.
Market Cap
47.50M
Enterprise Value
44.67M
1-Year Change
209.22%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $47.50M, a decrease of -26.49%. That is a compound annual growth rate of -8.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 47.98M | 72.88% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |